Evidence map›Paper›PMID 27890263›Full record

ReviewBest practice & research. Clinical haematology2016

Innate immunity and the new forward genetics.

Bruce Beutler

Abstract readReview
In one paragraph

Review in Best practice & research. Clinical haematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The Microbe, the Infection Enigma, and the Host.Annual review of microbiology · 2024
    Review
  2. Genetic Susceptibility to Fungal Infections.Advanced biomedical research · 2023
    Review
  3. eLife · 2020
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bruce BeutlerCenter for the Genetics of Host Defense, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8505, United States. Electronic address: Bruce.Beutler@UTSouthwestern.edu.

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Sequencing CoreP01AI070167 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI BEUTLER, BRUCE A · 2006 to 2016
$27.2M
Mutagenetic analysis of LPS responsesR37GM067759 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BEUTLER, BRUCE A · 2007 to 2016
$8.6M
NIAID NIH HHS P01 AI070167NIAID NIH HHS U19 AI100627NIGMS NIH HHS R37 GM067759
6 · The paper itself

Abstract

As it is a hard-wired system for responses to microbes, innate immunity is particularly susceptible to classical genetic analysis. Mutations led the way to the discovery of many of the molecular elements of innate immune sensing and signaling pathways. In turn, the need for a faster way to find the molecular causes of mutation-induced phenotypes triggered a huge transformation in forward genetics. During the 1980s and 1990s, many heritable phenotypes were ascribed to mutations through positional cloning. In mice, this required three steps. First, a genetic mapping step was used to show that a given phenotype emanated from a circumscribed region of the genome. Second, a physical mapping step was undertaken, in which all of the region was cloned and its gene content determined. Finally, a concerted search for the mutation was performed. Such projects usually lasted for several years, but could produce breakthroughs in our understanding of biological processes. Publication of the annotated mouse genome sequence in 2002 made physical mapping unnecessary. More recently we devised a new technology for automated genetic mapping, which eliminated both genetic mapping and the search for mutations among candidate genes. The cause of phenotype can now be determined instantaneously. We have created more than 100,000 coding/splicing mutations. And by screening for defects of innate and adaptive immunity we have discovered many "new" proteins needed for innate immune function.

Indexed as

Chromosome MappingMutationAnimalsHumansImmunity, InnateSignal TransductionForward geneticsGenetic mappingInnate immunityN-ethyl-N-nitrosoureaToll-like receptor

Identifiers

PMID27890263
PMCPMC5179328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.